Active Not RecruitingNCT04620759
Psilocybin for depression and alcohol use together
About this title
Read the official source — NCT04620759Medication studyAges 21–65United States
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: 21 years to 65 years. Other eligibility criteria apply.
- Listed locations
- BaltimoreSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 14, 2021
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 90
- Sponsor
- Johns Hopkins University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT04620759
- Official title
Show the full official title
Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Baltimore
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Johns Hopkins University, a university.
Does this study involve medication?
Yes. The study involves medication, including Psilocybin and Placebo.
Who can participate?
This study is for people with depression. Listed age limits: 21 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
